Burt Wealth Advisors Acquires 176 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Burt Wealth Advisors increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,041 shares of the healthcare conglomerate’s stock after purchasing an additional 176 shares during the quarter. UnitedHealth Group accounts for 2.1% of Burt Wealth Advisors’ portfolio, making the stock its 13th biggest holding. Burt Wealth Advisors’ holdings in UnitedHealth Group were worth $8,402,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. NewSquare Capital LLC bought a new position in UnitedHealth Group in the fourth quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the fourth quarter worth about $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth about $32,000. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have commented on UNH shares. Robert W. Baird cut UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price target for the company. in a research report on Wednesday, June 11th. JPMorgan Chase & Co. increased their target price on UnitedHealth Group from $405.00 to $418.00 and gave the stock an “overweight” rating in a research report on Friday. Oppenheimer cut their target price on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research report on Wednesday, May 14th. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Finally, Wolfe Research cut their target price on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research report on Tuesday, May 20th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $427.09.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Stephen J. Hemsley acquired 86,700 shares of the firm’s stock in a transaction dated Friday, May 16th. The stock was acquired at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the firm’s stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Trading Down 1.7%

Shares of NYSE UNH opened at $302.04 on Friday. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The business has a fifty day simple moving average of $359.15 and a two-hundred day simple moving average of $463.79. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market cap of $273.99 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 1.44 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter last year, the firm earned $6.91 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.93%. The ex-dividend date of this dividend is Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is presently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.